Newsfeed
Our protocol paper for the IMAGE trial investigating early detection using #melanoma surveillance photography is now published in @BioMedCentral.
https://doi.org/10.1186/s13063-023-07203-5
@DrVictoriaMar @AnneECust @hpsoyer @MonikaJanda @ByarsGabrielle @RMahumud @PabloFP_Syd
A #MerkelCellCarcinoma session will be part of the
@MASC_Trials ASM. Hear from Dr Wen Xu, @SandhuShahneen and MCC immunotherapy 'I-MAT' trial participant, John Mason, in Brisbane this Thursday 23 March👇
The MASC Trials ASM is on Thurs 23 March, Brisbane. If you want to attend, register NOW as we only have 6 seats left before we're booked out! The MASC Trials ASM is a satellite meeting of the Australasian Melanoma Conference, Brisbane, 24-25 March.
https://www.masc.org.au/asm-2023/
A #MerkelCellCarcinoma session will be part of the @MASC_Trials ASM. Hear from Dr Wen Xu, @SandhuShahneen and MCC immunotherapy trial participant, John Mason, at this face-to-face meeting in Brisbane on 23 March 👇
Only two weeks until the MASC Trials Annual Scientific Meeting & we only have 10 seats left before the meeting is booked out! Hear from experts in melanoma & skin cancer clinical trials, in-person at Brisbane Convention & Exhibition Centre, 23 March.
https://www.masc.org.au/asm-2023/
Mailing address:
AMIGOs
C/O Melanoma and Skin Cancer Trials
553 St Kilda Road
Melbourne, VIC 3004, Australia
General enquiries:
Email: amigos@masc.org.au
Mailing address:
Melanoma and Skin Cancer Trials
553 St Kilda Road
Melbourne, VIC 3004, Australia
General enquiries:
Email: hello@masc.org.au
